Acquired and Congenital von Willebrand Factor Abnormalities Congenital Cardiac Defects

Thromb Haemost 1986; 56(01): 111
DOI: 10.1055/s-0038-1661616

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

H Takahashi

First Department of Internal Medicine, Niigata University School of Medicine, Niigata 951, Japan
W Tatewaki

First Department of Internal Medicine, Niigata University School of Medicine, Niigata 951, Japan
R Nagayama

First Department of Internal Medicine, Niigata University School of Medicine, Niigata 951, Japan
M Hanano

First Department of Internal Medicine, Niigata University School of Medicine, Niigata 951, Japan
K Wada

First Department of Internal Medicine, Niigata University School of Medicine, Niigata 951, Japan
A Shibata

First Department of Internal Medicine, Niigata University School of Medicine, Niigata 951, Japan

References
1 Mannucci PM, Mari D. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand’s disease. Prog Clin Biol Res 1984; 150: 109-122
2 Lombardi R, Mannucci PM, Seghatchian MJ, Vicente Garcia V, Coppola R. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration. Br J Haematol 1981; 49: 61-68
3 Moake JL, Byrnes JJ, Troll JH, Rudy CK, Weinstein MJ, Colannino NM, Hong SL. Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome. Blood 1984; 64: 592-598
4 Gill JC, Wilson AD, Endres-Brooks J, Montgomery RR. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 1986; 67: 758-761